Curevac
- All
- News
-
Covid Vaccine From Germany's CureVac Just 48% Effective
Germany's CureVac announced Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, far lower than those developed by mRNA rivals BioNTech and Moderna.
-
CureVac Fails In Pivotal COVID-19 Vaccine Trial With 47% Efficacy
German biotech CureVac NV said on Wednesday its COVID-19 vaccine was only 47% effective in a late-stage trial, missing the study's main goal and throwing in doubt the potential delivery of hundreds of millions of doses to the European Union.
-
"Our Covid Vaccine Triggered Immune Response In Humans": CureVac
CureVac's experimental COVID-19 vaccine triggered an immune response in humans, it said on Monday, putting the German biotech company on track to start mass testing this year as the race to end the pandemic heats up.
-
Tesla CEO Elon Musk Test Drives Volkswagen's New Electric Car: Report
Elon Musk, the CEO of Tesla Inc visited Germany to meet several officials with projects related to the upcoming Gigafactory. The officials assured him that the company will get complete support from the German government for building its Gigafactory Berlin. We already know that Tesla is building a new Gigafactory outside Berlin and everyone assumed...
-
Tesla CEO, Elon Musk Discusses Vaccine Project And New Car Plant With German Politicians
Tesla Inc's CEO Elon Musk met with three German ministers and other senior politicians on Wednesday to discuss the progress of a collaboration between the car maker and a German biotech company and a planned electric vehicle factory.
-
Curevac Doesn't Rule Out Accelerated Approval For COVID-19 Vaccine
German biotechnology firm CureVac does not rule out a speedy approval process for its prospective vaccine against COVID-19, its chief executive was quoted as saying on Sunday.
-
Tesla To Make Molecule Printers For German COVID-19 Vaccine Developer CureVac
Tesla Inc is building mobile molecule printers to help make the potential COVID-19 vaccine being developed by CureVac in Germany, the electric-car maker's Chief Executive Officer, Elon Musk, tweeted on Wednesday. CureVac, an unlisted German company, has said it is developing portable, automated mRNA production units that it calls printers and which...
-
Tesla to Make Molecule Printers for German COVID-19 Vaccine Developer CureVac
Tesla is building mobile molecule printers to help make the potential COVID-19 vaccine being developed by CureVac in Germany, the electric-car maker's Chief Executive Officer, Elon Musk, tweeted on Wednesday.
-
Covid Vaccine From Germany's CureVac Just 48% Effective
Germany's CureVac announced Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, far lower than those developed by mRNA rivals BioNTech and Moderna.
-
CureVac Fails In Pivotal COVID-19 Vaccine Trial With 47% Efficacy
German biotech CureVac NV said on Wednesday its COVID-19 vaccine was only 47% effective in a late-stage trial, missing the study's main goal and throwing in doubt the potential delivery of hundreds of millions of doses to the European Union.
-
"Our Covid Vaccine Triggered Immune Response In Humans": CureVac
CureVac's experimental COVID-19 vaccine triggered an immune response in humans, it said on Monday, putting the German biotech company on track to start mass testing this year as the race to end the pandemic heats up.
-
Tesla CEO Elon Musk Test Drives Volkswagen's New Electric Car: Report
Elon Musk, the CEO of Tesla Inc visited Germany to meet several officials with projects related to the upcoming Gigafactory. The officials assured him that the company will get complete support from the German government for building its Gigafactory Berlin. We already know that Tesla is building a new Gigafactory outside Berlin and everyone assumed...
-
Tesla CEO, Elon Musk Discusses Vaccine Project And New Car Plant With German Politicians
Tesla Inc's CEO Elon Musk met with three German ministers and other senior politicians on Wednesday to discuss the progress of a collaboration between the car maker and a German biotech company and a planned electric vehicle factory.
-
Curevac Doesn't Rule Out Accelerated Approval For COVID-19 Vaccine
German biotechnology firm CureVac does not rule out a speedy approval process for its prospective vaccine against COVID-19, its chief executive was quoted as saying on Sunday.
-
Tesla To Make Molecule Printers For German COVID-19 Vaccine Developer CureVac
Tesla Inc is building mobile molecule printers to help make the potential COVID-19 vaccine being developed by CureVac in Germany, the electric-car maker's Chief Executive Officer, Elon Musk, tweeted on Wednesday. CureVac, an unlisted German company, has said it is developing portable, automated mRNA production units that it calls printers and which...
-
Tesla to Make Molecule Printers for German COVID-19 Vaccine Developer CureVac
Tesla is building mobile molecule printers to help make the potential COVID-19 vaccine being developed by CureVac in Germany, the electric-car maker's Chief Executive Officer, Elon Musk, tweeted on Wednesday.
